Analyst Reco. PDS Biotechnology Corporation

Equities

PDSB

US70465T1079

Market Closed - Nasdaq Other stock markets 21:00:00 01/05/2024 BST			5-day change	1st Jan Change
3.61 ^USD	+7.76%		+11.08%	-27.36%

03-28	B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating	MT
03-27	Empire Metals targets key milestones in Australia	AN

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating	03-28	MT
Oppenheimer Adjusts PDS Biotechnology Price Target to $20 From $23, Maintains Outperform Rating	11-15	MT
Oppenheimer Adjusts PDS Biotechnology Price Target to $23 From $24, Maintains Outperform Rating	15/08/23	MT
PDS Biotechnology Corporation Announces Interim Data Demonstrates 12-Month Survival Rate of 87% with PDS0101 in Combination with Keytruda (Pembrolizumab) for Head and Neck Cancer Patients	25/05/23	CI
HC Wainwright Adjusts Price Target on PDS Biotechnology to $21 From $15, Maintains Buy Rating	03/01/23	MT
B. Riley Lifts Price Target on PDS Biotechnology to $12 From $10, Cites Higher Probability of Success for Triplet Regimen; Buy Kept	29/12/22	MT
Chardan Increases Price Target on PDS Biotechnology to $16 From $15, Keeps Buy Rating	15/11/22	MT
B. Riley Securities Starts PDS Biotechnology at Buy With $10 Price Target	01/11/22	MT
Alliance Global Adjusts Price Target on PDS Biotechnology to $16 From $18, Reiterates Buy Rating	16/05/22	MT
PDS BIOTECHNOLOGY : HC Wainwright Adjusts Price Target on PDS Biotechnology to $15 From $20, Maintains Buy Rating	12/08/21	MT
PDS BIOTECHNOLOGY : Cantor Fitzgerald Starts PDS Biotechnology at Overweight With $25 Price Target	28/06/21	MT
PDS BIOTECHNOLOGY : Alliance Global Partners Adjusts Price Target on PDS Biotechnology to $18 From $6.50, Maintains Buy Rating	09/06/21	MT
PDS BIOTECHNOLOGY : Chardan Adjusts Price Target on PDS Biotechnology to $15 From $11, Maintains Buy Rating	09/06/21	MT
PDS BIOTECHNOLOGY : Oppenheimer Adjusts PDS Biotechnology's Price Target to $25 From $12, Maintains Outperform Rating	09/06/21	MT
PDS BIOTECHNOLOGY : HC Wainwright Adjusts PDS Biotechnology's PT to $20 from $8, Keeps Buy Rating	02/06/21	MT
PDS BIOTECHNOLOGY : Chardan Capital Adjusts Price Target on PDS Biotechnology to $11 From $10, Maintains Buy Rating	20/05/21	MT
PDS BIOTECHNOLOGY : Oppenheimer Adjusts PDS Biotechnology PT to $12 From $7, Maintains Outperform Rating	19/03/21	MT
PDS BIOTECHNOLOGY : HC Wainwright Adjusts PDS Biotechnology's Price Target to $8 from $6, Keeps Buy Rating	19/03/21	MT
PDS BIOTECHNOLOGY : Oppenheimer Initiates Coverage on PDS Biotechnology With Outperform Rating, $7 Price Target	04/12/20	MT
PDS BIOTECHNOLOGY : HC Wainwright Upgrades PDS Biotechnology to Buy From Neutral; Price Target is $6	10/11/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. PDS Biotechnology Corporation

Equities

PDSB

US70465T1079

Analyst Reco.

Filters